Completed
Brain imaging to understand HIV-associated neurocognitive disorder and predict response to cognitive training
Learn MoreReporting
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
Learn MoreReporting
Use of non-invasive methods for diagnosis of non-alcoholic steatohepatitis (NASH) in HIV patients and therapeutic use of vitamin E
Learn MoreReporting
Bone Antiresorptive Therapy with AntiRetroviral Initiation (BATARI) Pilot Trial
Learn MoreCompleted
Can valacylovir attenuate inflammation in ART-treated HIV-infected individuals with herpes simplex virus type 2? Trial results
Learn MoreReporting
Assessing feasibility of collecting repeated blood and swab samples for herpesviruses in HIV-infected individuals hospitalized with acute illness
Learn MoreReporting
Pilot project to implement a step-wise investigation that includes Cerebrospinal Fluid analysis as a standard of care for HIV+ individuals with cognitive symptoms
Learn MoreCompleted
Counselling programme in combination with nicotine replacement therapy
Learn MoreCompleted
Renal monitoring in people living with HIV
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
